Qinghai Spring Medicinal Resources Technology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 102.77 million compared to CNY 45.41 million a year ago. Revenue was CNY 105.39 million compared to CNY 47.05 million a year ago.

Net loss was CNY 48.94 million compared to CNY 49.71 million a year ago. Basic loss per share from continuing operations was CNY 0.083 compared to CNY 0.085 a year ago. Diluted loss per share from continuing operations was CNY 0.083 compared to CNY 0.085 a year ago.